Rankings
▼
Calendar
NVAX FY 2019 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$19M
-45.6% YoY
Gross Profit
-$95M
-510.0% margin
Operating Income
-$121M
-646.1% margin
Net Income
-$130M
-697.1% margin
EPS (Diluted)
$-5.40
Cash Flow
Operating Cash Flow
-$137M
Free Cash Flow
-$138M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$173M
Total Liabilities
$359M
Stockholders' Equity
-$186M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19M
$34M
-45.6%
Gross Profit
-$95M
$34M
-377.6%
Operating Income
-$121M
-$174M
+30.7%
Net Income
-$130M
-$185M
+29.6%
← Q4 2018
All Quarters
Q1 2019 →